Haemonetics Corp
HAE· NYSE
HAEHaemonetics Corp
Filed May 25, 2022 · 10-K · 53 days after period end · 0000313143-22-000024
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021 | Q4 2020 | Q4 2019 |
|---|---|---|---|---|
| Revenue | $265.00M | $225.03M | $238.49M | $249.30M |
| Net Income | $9.74M | -$11.04M | $17.62M | $20.84M |
| EPS Diluted | — | -$0.22 | $0.34 | $0.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
ended Apr 2, 2022 · filed May 25, 2022 · 53 d after period end
